Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can rehabilitation boost confidence in fibrotic lung disease?

NCT ID NCT06027333

Knowledge-focused Sponsor: Berner Reha Zentrum AG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This observational study follows patients with fibrotic interstitial lung disease (ILD) to see how their self-efficacy and quality of life change over time. Participants either undergo inpatient pulmonary rehabilitation or receive regular outpatient care. Researchers use questionnaires at baseline and follow-up to measure changes. The findings may help design a future educational and self-management program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
This study could reveal how self-efficacy and quality of life change over time in fibrotic ILD, informing future educational and self-management programs.
What could go wrong
As an observational study, it cannot prove cause and effect. Results may not apply to all patients, and the small size limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with fibrotic lung disease participating in an inpatient rehabilitation or in outpatient consultations for interstitial lung disease

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria are: * For Berner Reha Zentrum only: Diagnosis of a FILD as major indication for pulmonary rehabilitation * For Inselspital only: Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose * Age ≥ 18 years * Written informed consent Exclusion criteria are: * Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures * Sarcoidosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibrotic lung disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibrotic lung disease Interstitial lung disease Patient education Quality of life Self-efficacy Self-management

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Berner Reha Zentrum, Rehabilitation & Sports Medicine, Insel Group, University Hospital Berne

    RECRUITING

    Bern, Heiligenschwendi, 3365, Switzerland

  • Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern

    RECRUITING

    Bern, Canton of Bern, 3010, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.